In the WT groups, PD-L1 blockade reduced tumor growth, which was further enhanced by administration of i.v. 1 g/kg VC, while no effect was seen for the combined treatment in the TET2-KO groups (Figure 1D). The gene discussed is TET2; the disease is neoplasm.